We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How investigators and sponsors should manage clinical trials during COVID-19
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to use a clinical audit to evaluate your digital health product.
How to show the MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Guidance for health professionals on diagnoses, prevention and treatment of meningococcal disease.
Actions that trial sponsors should consider to build resilience into clinical trial design
Guidance on investigating Middle East respiratory syndrome coronavirus (MERS-CoV), public health management of suspected UK cases and advice to travellers.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).